Factory's loss of licence halves supply of flu vaccine to USBMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7471.876-b (Published 14 October 2004) Cite this as: BMJ 2004;329:876
- Owen Dyer
US health officials are having to cope with the loss of half of this season's expected supply of flu vaccine, after last week's decision by the UK Medicines and Healthcare Products Regulatory Agency to temporarily shut down the Liverpool factory of one of the world's largest vaccine manufacturers.
The agency revoked the manufacturing licence of Chiron Corporation's factory for three months pending further investigation, after an inspection of the plant raised concerns over possible contamination. The agency gave no details, but in August Chiron acknowledged that some four million doses of its Fluvirin flu vaccine were potentially contaminated with Serratia marcescens, a bacterium …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial